Bringas M. E., Morales-Medina J. C., Flores-Vivaldo Y., Negrete-Diaz J. V., Aguilar-Alonso P., Leon-Chavez B. A., Lazcano-Ortiz Z., Monroy E., Rodriguez-Moreno A., Quirion R., Flores G. (2012). Clozapine administration reverses behavioral, neuronal, and nitric oxide disturbances in the neonatal ventral hippocampus rat, Neuropharmacology, 62(4), 1848-57. Find out more.

Efthimiadi L., Farso M., Quirion R., Krantic S. (2012). Cyclin D1 induction preceding neuronal death via the excitotoxic NMDA pathway involves selective stimulation of extrasynaptic NMDA receptors and JNK pathway, Neurodegener Dis, 10(1-4), 80-91. Find out more.

Hong Y., Hay D. L., Quirion R., Poyner D. R. (2012). The pharmacology of adrenomedullin 2/intermedin, British journal of pharmacology, 166(1), 110-20. Find out more.

Krantic S., Goutagny R., Cavanagh C., Chabot J.G., Colby-Milley J., Williams S., Quirion R. (2012). Nouveaux gènes impliqués dans la mémoire: impact sur la maladie d’Alzhiemer, Annales Académie nationale de médecine, 59-66.

Krantic S., Isorce N., Mechawar N., Davoli M.A., Vignault E., Albuquerque M., Chabot J. G., Moyse E., Chauvin J.P., Aubert I., McLaurin J., Quirion R. (2012). Hippocampal GABAergic neurons are susceptible to amyloid-beta toxicity in vitro and are decreased in number in the Alzheimer's disease TgCRND8 mouse model, J Alzheimers Dis, 29(2), 293-308. Find out more.

Menard C., Quirion R. (2012). Successful Cognitive Aging in Rats: A Role for mGluR5 Glutamate Receptors, Homer 1 Proteins and Downstream Signaling Pathways, PloS one, 7(1), e28666. Find out more.

Menard C., Quirion R. (2012). Group 1 metabotropic glutamate receptor function and its regulation of learning and memory in the aging brain, Front Pharmacol, 3, 182. Find out more.

Morales-Medina J. C., Dominguez-Lopez S., Gobbi G., Beck-Sickinger A. G., Quirion R. (2012). The selective neuropeptide Y Y(5) agonist [cPP(1-7),NPY(19-23),Ala(31),Aib(32),Gln(34)]hPP differently modulates emotional processes and body weight in the rat, Behav Brain Res. Find out more.

Morales-Medina J.C., Dumont Y., Benoit C.E., Bastianetto S., Flores G., Fournier A., Quirion R. (2012). Role of neuropeptide Y Y(1) and Y(2) receptors on behavioral despair in a rat model of depression with co-morbid anxiety, Neuropharmacology, 62(1), 200-208. Find out more.

Morales-Medina J.C., Dumont Y., Bonaventure P., Quirion R. (2012). Chronic administration of the Y(2) receptor antagonist, JNJ-31020028, induced anti-depressant like-behaviors in olfactory bulbectomized rat, Neuropeptides. Find out more.

Sun C., Meng Q., Zhang L., Wang H., Quirion R., Zheng W. (2012). Glutamate attenuates IGF-1 receptor tyrosine phosphorylation in mouse brain: Possible significance in ischemic brain damage, Neuroscience research, 74(3-4), 290-7. Find out more.

Wang D., Chen T., Gao Y., Quirion R., Hong Y. (2012). Inhibition of SNL-induced upregulation of CGRP and NPY in the spinal cord and dorsal root ganglia by the 5-HT(2A) receptor antagonist ketanserin in rats, Pharmacol Biochem Behav, 101(3), 379-86. Find out more.

Wang H., Zhang Q., Zhang L., Little P. J., Xie X., Meng Q., Ren Y., Zhou L., Gao G., Quirion R., Zheng W. (2012). Insulin-like growth factor-1 induces the phosphorylation of PRAS40 via the PI3K/Akt signaling pathway in PC12 cells, Neurosci Lett, 516(1), 105-9. Find out more.

Wen Q., Wang H., Little P. J., Quirion R., Zheng W. (2012). Forkhead family transcription factor FoxO and neural differentiation, Neurogenetics, 13(2), 105-13. Find out more.

Yu W., Mechawar N., Krantic S., Chabot J.G., Quirion R. (2012). Upregulation of astrocytic alpha7 nicotinic receptors in Alzheimer's disease brain- possible relevant to amyloid pathology, Mol Neurodegener, 7 Suppl 1, 07. Find out more.

Zheng W., Wang H., Zeng Z., Lin J., Little P. J., Srivastava L., Quirion R. (2012). The possible role of the Akt signaling pathway in schizophrenia, Brain Res, 1470, 145-58. Find out more.